Me Cure Industries records 45% revenue growth, declares N0.6 bn dividend
By Peter Egwuatu Despite significant macroeconomic headwinds, including inflationary pressures and high interest rates, a frontline pharmaceutical company, Me Cure Industries, remained resilient and recorded notable progress across key financial and operational metrics in the financial year ended December 31, 2024. The company’s revenue rose impressively by 45%, to N46 billion in 2024 from N31.7 […]

